Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237443 · ClinicalTrials.gov registry record · Phase 4
Mask Ventilation Before and After Neuromuscular Blockade
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 210
- Enrollment target
NCT02237443: Completed Phase 4 study, sponsored by University of Washington.
NCT02237443 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 210 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02237443, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 210 participants
- Enrollment target
Study Summary
Anesthesia providers are taught to "test" that they can properly ventilate a patient's lungs before administering a neuromuscular blocking drug (NMBD), rendering the patient apneic. This is a traditional teaching, not based on empirical evidence. The investigators primary hypothesis is that ventilation after the administration of NMBDs is non-inferior with that before their administration with respect to the composite safety endpoint of inadequate (MVi) and dead-space only (Vds) ventilation.
Primary Outcome
The difference in average exhaled volumes per breath between study periods before and after neuromuscular blocker administration.
Interventions
- DRUG Rocuronium
- DRUG Vecuronium Bromide
- DRUG Succinylcholine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-02 |
| Phase | Phase 4 |
What the finished NCT02237443 record still lists
NCT02237443 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 3 interventions - of which Rocuronium is the first listed.
NCT02237443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02237443 about?
NCT02237443 is a clinical study titled "Mask Ventilation Before and After Neuromuscular Blockade". Anesthesia providers are taught to "test" that they can properly ventilate a patient's lungs before administering a neuromuscular blocking drug (NMBD), rendering the patient apneic. This is a traditional teaching, not based on empirical evidence. The investigators primary hypothesis is that ventilat...
What is the current status of trial NCT02237443?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 210 participants. The study started on 2014-08. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02237443?
The interventions under investigation include: Rocuronium (DRUG), Vecuronium Bromide (DRUG), Succinylcholine (DRUG).
Who is sponsoring clinical trial NCT02237443?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02237443's enrollment target sits among peer trials
210 398th of 2000 higher than 1,602 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia